Inventor
WHEELER JOHN
US29 patents
⚠️ This page may combine multiple inventors who share the name “WHEELER JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN BIOTECH INC
13 patentsUS9102737B2Aug 11, 2015
Human anti-CD27 antibodies, methods and uses
JANSSEN BIOTECH INC36 citations96
US9212227B2Dec 15, 2015
ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
JANSSEN BIOTECH INC13 citations91
US9090694B2Jul 28, 2015
ST2L antibody antagonists
JANSSEN BIOTECH INC19 citations91
US9683046B2Jun 20, 2017
Nucleic acid molecules encoding anti-CD27 antibodies
JANSSEN BIOTECH INC7 citations83
US9951137B2Apr 24, 2018
ST2L antagonists and methods of use
JANSSEN BIOTECH INC4 citations82
US10301392B2May 28, 2019
Methods of inhibiting T-cell mediated B-cell antibody production using anti-CD27 antibodies
JANSSEN BIOTECH INC3 citations72
US10450377B2Oct 22, 2019
ST2L antagonists and methods of use
JANSSEN BIOTECH INC1 citations71
US11414484B2Aug 16, 2022
Anti-CCL17 antibodies
JANSSEN BIOTECH INC1 citations68
US11732050B2Aug 22, 2023
Neutralizing human anti-CD27 antibodies
JANSSEN BIOTECH INC0 citations61
US9944697B2Apr 17, 2018
Anti-CCL17 antibodies
JANSSEN BIOTECH INC1 citations58
US8906649B2Dec 9, 2014
Antibodies binding human collagen II
JANSSEN BIOTECH INC2 citations58
US10689453B2Jun 23, 2020
Methods of inhibiting naive T-cell proliferation using anti-CD27 antibodies
JANSSEN BIOTECH INC0 citations51
US9248194B2Feb 2, 2016
Affinity peptides toward infliximab
JANSSEN BIOTECH INC0 citations46
JANSSEN PHARMACEUTICA NV
3 patentsUS9850310B2Dec 26, 2017
CD123 binding agents and uses thereof
JANSSEN PHARMACEUTICA NV23 citations90
US12234280B2Feb 25, 2025
Anti-PHF-tau antibodies and uses thereof
JANSSEN PHARMACEUTICA NV0 citations56
US10633435B2Apr 28, 2020
Anti-PHF-tau antibodies and uses thereof
JANSSEN PHARMACEUTICA NV1 citations55
CENTURY THERAPEUTICS INC
3 patentsUS11661459B2May 30, 2023
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
CENTURY THERAPEUTICS INC0 citations58
US12269888B2Apr 8, 2025
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
CENTURY THERAPEUTICS INC0 citations47
US11883432B2Jan 30, 2024
Chimeric antigen receptor system with adaptable receptor specificity
CENTURY THERAPEUTICS INC0 citations44